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Level of renal function at the initiation of dialysis in the U.S. patients enrolled in the ESRD program in the U.S. has
end-stage renal disease population. grown from approximately 10,000 beneficiaries in 1973
Background. More than 285,000 individuals in the United to 86,354 in 1983 and 287,515 as of December 31, 1996States suffer from end-stage renal disease (ESRD) and are
[2]. During the last decade, the prevalence of ESRD hastreated predominantly by dialysis. Despite the high cost and
nearly doubled, corresponding to an annual increase ofpoor outcomes of dialysis treatment for ESRD, there are few
data about the level of renal function at the onset of ESRD approximately 9%. The rising prevalence of treated
and no established medical criteria for the initiation of dialysis. ESRD can be attributed primarily to the rapid increase
Methods. We report the level of serum creatinine and glo- in the incidence of treated ESRD patients. In fact, 73,091merular filtration rate (GFR) in 90,897 patients who began
new patients entered the ESRD program in 1996 alonedialysis in the U.S. between April 1995 through September
[2]. Patients with ESRD consume a disproportionate1997. Data were obtained from the U.S. Renal Data System.
GFR was predicted by an equation developed from the Modi- share of the national health care resources. The annual
fication of Diet in Renal Disease Study. cost of treating patients on dialysis has been estimated
Results. The mean (sd) serum creatinine was 8.5 (3.8) mg/dl.
to be between $48,351 and $68,891 for patients on hemo-The mean (sd) predicted GFR was 7.1 (3.1) ml/min/1.73 m2,
dialysis and $33,781 and $45,420 for patients on perito-with a range from 1 to 42 ml/min/1.73 m2. The proportion of
patients with predicted GFR of .10, 5 to 10, and ,5 ml/min/ neal dialysis [3, 4]. Furthermore, in 1996, the cost of care
1.73 m2 was 14, 63, and 23%, respectively. The mean predicted of U.S. patients with ESRD was estimated at $14.55 billion
GFR was significantly lower among younger patients, women, [2]. Despite the resources committed to the treatment of
African Americans, patients with a higher body weight, pa-
ESRD, these patients experience a significant morbiditytients with ESRD because of diseases other than diabetes,
and a reduced quality of life. Hospitalization rates foruninsured patients, patients who were employed, homemakers
or students, and patients selecting hemodialysis. patients with ESRD are higher than those for age- and
Conclusions. There is wide variation in renal function at gender-matched comparative cohorts. In addition, the
the initiation of dialysis in the U.S. ESRD population, and a mortality among dialysis patients remains high. The lifesubstantial fraction of patients start dialysis at very low levels
expectancy of dialysis patients in the United States is 16of predicted GFR. Further analyses are needed to examine
to 37% of the age-, gender-, and race-matched popula-the factors associated with late initiation of dialysis and its
impact on the cost and outcomes of ESRD. tion [5].
Although four decades have passed since Scribner et
al’s introduction of chronic hemodialysis in 1960 at the
In 1972, the United States Congress legislated the pro- University of Washington [6], there are no well-defined
vision of health care coverage under Medicare for all criteria regarding the level of renal function at which
patients with end-stage renal disease (ESRD), regardless dialysis should be optimally initiated. In the absence
of age [1]. Since the introduction of this entitlement in of such criteria, payers have established administrative
the Social Security Amendments of 1972, the number of criteria that define levels of serum creatinine or creati-
nine clearance beyond which payment would be denied,
unless justification is provided. These administrative cri-Key words: serum creatinine, glomerular filtration rate, chronic renal
failure, dialysis start. teria were primarily promulgated to prevent physicians
from starting patients on dialysis earlier than required.Received for publication March 23, 1999
Unfortunately, these administrative regulations have be-and in revised form June 30, 1999
Accepted for publication July 19, 1999 come de facto standards of practice, without medical
evidence supporting their use. Consequently, the appro- 1999 by the International Society of Nephrology
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priate timing for the initiation of dialysis remains a sub- patients and within 10 days prior to the initiation of
dialysis in 77% of the patients.ject of debate.
One of the major obstacles to the development of
Patient populationevidence-based guidelines for timing of initiation of dial-
The population for this analysis consisted of all pa-ysis has been the lack of a simple test to reliably estimate
tients who initiated chronic dialysis in the United Statesthe level of glomerular filtration rate (GFR). The mea-
for whom a new 2728 form was received by HCFA andsurement of creatinine clearance requires a timed urine
who were included in the September 1997 update of thecollection, which is difficult in routine clinical practice.
Medevid file of the USRDS. Since the new version ofSerum creatinine, the most widely used index of renal
the 2728 form was introduced in April 1995, only patientsfunction, is influenced by age, gender, and race, as well
who started dialysis at or after that date were included.as by the level of GFR. Consequently, analyses based
To limit this analysis to patients whose first ESRD treat-on serum creatinine may reveal variations in timing of
ment modality was dialysis, patients who received athe initiation of dialysis that reflect variables other than
transplant or returned to dialysis were excluded. Patientsrenal function, and might suggest differential access to
who were less than 18 years of age and those with morecare for subgroups within the population based on demo-
than one 2728 form in the database were also excluded.graphic characteristics. Furthermore, physicians may be
compelled to start dialysis too late out of fear of being Glomerular filtration rate prediction
denied reimbursement. The delayed initiation of dialysis
As described elsewhere, the MDRD Study equationcould arguably be one of the reasons for the high morbid-
was derived using stepwise linear regression to predictity and mortality among ESRD patients.
the logarithm of GFR based on demographic and serumTo define the patterns of initiation of dialysis in the
biochemical values from 1628 patients who enrolled inU.S., we examined the serum creatinine levels at the
the baseline period of the MDRD Study [7]. Thus, theinitiation of dialysis among patients who started dialysis
equation to predict GFR is a multiplicative model:between April 1995 and June 1997. The GFR was esti-
mated using the prediction equation recently developed GFR 5 170 3 [PCr]20.999 3 [Age]20.176
from the Modification of Diet in Renal Disease (MDRD)
3 [0.762 if female] 3 [1.180 if black]Study [7]. This equation provides a more accurate esti-
mate of GFR than either measured creatinine clearance 3 [SUN]20.170 3 [SAlb]10.318
or other commonly used equations.
where GFR is in ml/min per 1.73 m2 of body surface
area, and serum (plasma) creatinine (PCr) is in mg/dl.
Age is in years, SUN is in mg/dl, and serum albuminMETHODS
(SAlb) is in g/dl.Data
Patients in the MDRD Study baseline cohort were
The Medical Evidence (Medevid) Standard Analysis aged 18 to 70 years, with serum creatinine (SCr) 1.4 toFile of the United States Renal Data System (USRDS) 7.0 mg/dl in men and 1.2 to 7.0 mg/dl in women. Patients
contains all data from the new version of the ESRD with insulin-requiring diabetes and renal transplant re-
Medical Evidence Form, which is also known as the cipients were excluded. Mean (sd) GFR, measured by
HCFA 2728 Form. This form is completed by dialysis 125I-iothalamate clearance, was 39.8 (21.2) ml/min per
units or transplant centers in all patients beginning or 1.73 m2. The MDRD Study equation has been validated
returning to ESRD treatment (dialysis or transplanta- in patients at the onset of ESRD (abstract; Levey et al,
tion) in the United States whether they are covered by J Am Soc Nephrol 9:153, 1998) but has not been validated
Medicare (approximately 92% of all new ESRD patients) in patients with diabetic renal disease. Of the 1628 pa-
or another type of insurance [5]. tients, 98 (6%) had non–insulin-dependent diabetes mel-
The new version of the 2728 form contains demo- litus. The relationship of this condition to log GFR was
graphic data, insurance, comorbid conditions, cause of not significant in the multivariable linear regression anal-
ESRD, functional status, employment, ESRD treatment ysis. The mean predicted GFR was 3% lower in diabetic
modality selected, and laboratory information. The labo- patients (multiplication factor 5 0.97, 95% CI, 0.94 to
ratory values recorded should be obtained within 45 days 1.01, P 5 0.19). Inclusion of this variable in the prediction
prior to the initiation of dialysis and should include se- equation did not contribute to the explanation of the
rum creatinine, blood urea nitrogen (BUN), hemoglobin, variability of GFR (change in the model R2 was 0%).
hematocrit, serum albumin and the lower limit of normal The percentage of variability (R2) in the logarithm
for serum albumin, and the dates of the tests. Serum of predicted GFR accounted for by variability in the
creatinine, albumin, and BUN were obtained within five logarithm of measured GFR in the MDRD Study base-
line cohort was 90.3%. By contrast, the measured creati-days prior to the initiation of dialysis in 63% of the
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nine clearance or creatinine clearance predicted by the inability to transfer, inability to ambulate, initial dialysis
modality, year of initiation of dialysis, and ESRD net-Cockcroft and Gault equation [8] overestimated mea-
sured GFR by 19 or 16%, respectively. After adjustment work (a geographic administrative region). For both
models, the P value for all comparisons was P , 0.001,for this overestimation, R2 for the correlation of the
logarithm of measured GFR with the logarithm of mea- which is not unexpected given the large sample size.
Calculations were performed using SAS version 6.12sured or predicted creatinine clearance was 86.6 or
84.2%, respectively. (SAS Institute Inc., Cary, NC, USA).
Analytical methods
RESULTS
Serum creatinine, other laboratory values, and demo-
Demographics and clinical characteristicsgraphic data were abstracted from the 2728 form. Labo-
ratory values dated more than 45 days prior to the date Forms on a total of 168,334 patients were available.
Excluded were 7486 patients with missing informationof initiation of dialysis were excluded. Acceptable values
for serum creatinine were 2 to 30 mg/dl. To compare on the date of initiation of dialysis or who began dialysis
before April 1, 1995, 3279 patients who received a trans-predicted GFR and serum creatinine in the same pa-
tients, we restricted the analysis to patients who had plant or returned to dialysis, 1548 patients who were less
than 18 years of age, and 945 patients with more thanvalid data for serum creatinine, the variables used to
predict GFR with the MDRD Study equation (SCr, age, one 2728 form. Of the remaining 155,076 patients, 141,434
(91%) had serum creatinine between 2 and 30 mg/dl;gender, race, BUN, and serum SAlb), and other covariates
used for subsequent multivariable models. No attempt 101,856 (66%) had data available for predicting GFR
using the MDRD Study equation, and 90,897 (59%) hadwas made to impute missing data.
Age was categorized in 10-year intervals for descrip- data for all the covariates included in the multivariable
models. Demographic and clinical characteristics of thetive purposes and as a continuous variable for the multi-
variable models. Race was categorized as African Ameri- overall population and the analysis subpopulation of
90,897 patients were nearly identical (Table 1).can or non-African American (Caucasian and other
races). Insurance status was categorized as private (any
Serum creatinineemployee group health or other private insurance; refer-
ence group), Medicare only, Medicaid only, Medicare The mean (sd) and median predialysis serum creati-
nine were 8.5 (3.8) and 7.9 mg/dl, respectively. The lowestand Medicaid only, Veterans Affairs (VA) and other
insurance(s), or no insurance. Employment status was (25%) and the highest (75%) quartiles were ,6.1 and
.10 mg/dl, respectively. Distribution of serum creatininedefined as employment six months prior to initiation of
dialysis and was categorized as employed/student/home- is presented in Figure 1A. The mean SCr was significantly
higher among younger patients, men, African Ameri-maker, unemployed, and other (retired because of age/
preference, retired because of disability, or medical leave cans, and those with weight above the mean (P , 0.001)
(Fig. 2A). The mean SCr was also higher in patients withof absence). Gender, ability to transfer, ability to ambu-
late, and dialysis modality were considered to be dichoto- causes of ESRD other than diabetic nephropathy com-
pared with patients with diabetic nephropathy. The dif-mous variables. Dialysis modality (hemodialysis or peri-
toneal dialysis) was defined as the anticipated long-term ferences in mean serum creatinine by age, gender, race,
and weight were observed in patients with or withoutprimary type of dialysis at ESRD start. Body mass index
(BMI; measured in kg/m2) was estimated with the follow- diabetes as the cause of ESRD (Table 2). Patients with
higher BUN or higher serum albumin also had highering formula: BMI 5 weight/height2. Patients with ESRD
caused by diabetic nephropathy were compared with mean SCr.
The differences in mean SCr by insurance, employment,patients with other causes of ESRD because diabetic
nephropathy is the largest single cause of ESRD, ac- inability to transfer, inability to ambulate, initial dialysis
modality, and year were statistically significant (P ,counting for 42.3% of incident cases in 1996 [2].
Descriptive statistics were obtained for serum creati- 0.001; Table 3). Patients with no insurance had the high-
est mean SCr, followed by those covered by Medicaid.nine and predicted GFR for the overall population and
for several subgroups. Univariate analyses for serum cre- Patients who were employed, students, or homemakers
had a higher mean SCr than unemployed patients, thoseatinine and for predicted GFR were performed using
t-tests or analysis of variance (ANOVA) to compare retired because of age, preference, or disability, or those
on medical leave of absence. Patients able to transfer ormeans between levels of each variable. The mean serum
creatinine and predicted GFR were compared between ambulate had a higher mean SCr than their counterparts.
Patients who selected hemodialysis had a higher meanlevels of each variable by constructing two multivariable
generalized linear models that included age, gender, SCr than those who selected peritoneal dialysis. Finally,
the mean and median SCr declined from 1995 to 1997.race, cause of ESRD, weight, insurance, employment,
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Table 1. Demographic and clinical characteristics of the overall population and the analysis subpopulation
Overall Analysis
population subpopulation
(N 5 155,076)a (N 5 90,897)
Demographics
Mean age, years (sd) 61 (16) 62 (16)
Gender, female 47% 47%
Race
Caucasian 61% 62%
African American 30% 29%
Other 9% 9%
Socioeconomic factors
Insurance status
Employer group health insurance (private) 24% 25%
Medicare only 15% 14%
Medicaid only 11% 11%
Medicare and Medicaid 11% 12%
Veterans Affairs and other insurances 31% 31%
None 8% 7%
Employment status
Employed/student/homemaker 27% 27%
Unemployed 19% 19%
Retired because of age/preference or disability and medical leave of absence 54% 54%
Cause of ESRD
Diabetic nephropathy 43% 44%
Hypertensionb 27% 26%
Glomerulonephritis 13% 14%
Other 17% 16%
Initial dialysis modality
Hemodialysis 87% 87%
Peritoneal dialysis 13% 13%
Dialysis start years
1995 (April–Dec) 33% 33%
1996 (Jan–Dec) 48% 48%
1997 (Jan–June) 19% 19%
Clinical and laboratory parameters
Mean weight (sd) kg 73 (20) 73 (20)
Mean height (sd) cm 168 (11) 168 (11)
Mean body mass index (sd) kg/m2 26 (7) 26 (7)
Mean BUN (sd) mg/dl 96 (34) 96 (33)
Mean serum creatinine (sd) mg/dl 8.6 (3.8) 8.5 (3.8)
Mean serum albumin (sd) g/dl 3.2 (0.7) 3.2 (0.7)
a Numbers vary for each variable (range 110,843–155,076)
b It includes ESRD secondary to hypertensive nephrosclerosis, renal artery stenosis and occlusion, and cholesterol emboli
Multivariable analysis showed that the differences in as large as for serum creatinine (Fig. 2B). The differences
in the mean predicted GFR by age, gender, race, andmean adjusted SCr were similar to the differences in mean
unadjusted SCr and remained statistically significant (data weight were observed in patients with or without diabe-
tes as the cause of ESRD (Table 2). Patients with highernot shown).
BUN or lower serum albumin had a lower predicted
Predicted glomerular filtration rate mean GFR.
Statistically significant differences in mean predictedThe mean (sd) and median predicted GFR were 7.1
(3.1) and 6.6 ml/min/1.73 m2, respectively, with a range GFR by insurance, employment, inability to transfer,
inability to ambulate, initial dialysis modality, and yearfrom 1 to 42 ml/min/1.73 m2. The lowest (25%) and the
highest (75%) quartiles were ,5.1 and .8.5 ml/min/1.73 were also observed (P , 0.001; Table 3). Patients with
no insurance had the lowest mean predicted GFR, fol-m2. Distribution of predicted GFR is presented in Figure
1B. The proportion of patients with a predicted GFR of lowed by those covered by Medicaid. Patients who were
employed, students, or homemakers had a lower mean.10, 5 to 10, and ,5 ml/min/1.73 m2 was 14, 63, and 23%,
respectively. The mean predicted GFR was significantly predicted GFR than unemployed patients, those retired
because of age, preference, or disability, or those onlower among younger patients, women, African Ameri-
cans, patients with weight above the mean, and patients medical leave of absence. Patients able to transfer or
ambulate had a lower predicted mean GFR than theirwith ESRD caused by diseases other than diabetes (P ,
0.001), but the differences between subgroups were not counterparts. Patients who selected hemodialysis had a
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Fig. 1. Distribution of serum creatinine and
predicted glomerular filtration rate (GFR) in
the analytic subpopulation. Study population
includes 90,897 patients with new onset ESRD
who initiated dialysis in the United States be-
tween April 1995 and September 1997 with
serum creatinine 2 to 20 mg/dl in whom com-
plete data were available (complete descrip-
tion in text). In A, mean is 8.5 6 3.8 and the
median is 7.9; in B, the mean is 7.1 6 3.1 and
the median is 6.6. Percents may not total 100%
because of rounding.
lower mean predicted GFR than those who selected peri- Limited published data are available regarding the
toneal dialysis. Finally, the mean and median GFR at level of renal function at initiation of chronic dialysis.
the initiation of dialysis increased from 1995 to 1997. Among 680 patients in the CANUSA Study, the mean
Multivariable analysis showed that the differences in the (sd) GFR estimated from the average of urea and creati-
mean adjusted predicted GFR were similar to the differ- nine clearance was 3.8 (sd) ml/min/1.73 m2 [9]. In con-
ences in the mean unadjusted predicted GFR and re- trast, among 88 patients who reached ESRD in the
mained statistically significant (data not shown). MDRD Study randomized cohort, the mean (sd) mea-
sured GFR was 9.1 (3.0) ml/min/1.73 m2 (abstract; Levey
et al, J Am Soc Nephrol 9:153, 1998) [10]. The meanDISCUSSION
predicted GFR in our study is higher than that reportedThis study provides the first comprehensive descrip-
in the CANUSA Study but is lower than that reportedtion of current patterns and secular trends in the timing
in the MDRD Study. The lower GFR among patients inof initiation of dialysis among patients with ESRD in
the CANUSA Study could be explained by the fact thatthe United States and the factors that influence these
the average of the urea and creatinine clearance usedpatterns. Our results demonstrate a wide variation in the
by the investigators slightly underestimates GFR [7] andlevel of renal function at the start of dialysis among
that the urea and creatinine clearances were measuredESRD patients in the United States (Fig. 1). Among
at one to two months after the initiation of peritoneal90,897 patients who began chronic dialysis between 1995
dialysis. By contrast, the higher GFR at start of dialysisand 1997, with SCr from 2 to 30 mg/dl, the predicted GFR
among patients in the MDRD Study probably reflectsranged from .15 ml/min/1.73 m2 to ,2 ml/min/1.73 m2.
timely referral for initiation of dialysis in a cohort ofThe mean SCr and predicted GFR at initiation of dialysis
carefully monitored patients, and that the final measure-were 8.5 6 3.8 mg/dl and 7.1 6 3.1 ml/min/1.73 m2, respec-
tively. ment of GFR was obtained at a median interval of ap-
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Fig. 2. Comparison of mean serum creatinine
and mean predicted glomerular filtration rate
(GFR) in subgroups within the analytic sub-
population. Symbol is (j), patient characteris-
tics of age .65 years, male, African American
race (blacks), weight $73 kg, and causes of
end-stage renal disease (ESRD) other than
diabetes (P , 0.001 for all comparisons).
proximately three months prior to the onset of dialysis. for only 5 to 10% of excreted creatinine. Therefore, values
for creatinine clearance closely approximate values forThus, the level of GFR predicted from the MDRD Study
equation in this analysis of USRDS data is consistent GFR. In normal individuals, urine creatinine excretion
reflects muscle mass and, to a lesser extent, meat intake.with the few published reports on this subject. However,
even this may be an overestimation of the GFR at initia- Therefore, at any given level of GFR, individuals with
higher muscles mass, including men, younger individuals,tion of dialysis in the United States, as laboratory values
obtained up to 45 days prior to the initiation of dialysis African Americans, and individuals with higher meat
intake, have slightly higher SCr values at normal GFR.were used in the prediction of GFR (23% of patients
had the relevant laboratory values dated more than 10 In patients with chronic renal disease, renal tubular se-
cretion of creatinine is enhanced; consequently, creati-days prior to the initiation of dialysis).
The wide variation in predicted GFR at the initiation nine clearance overestimates GFR by a larger fraction.
On the other hand, urine creatinine excretion is reducedof dialysis in part reflects the widespread use of SCr as a
guide to the level of renal function in patients with because of the restriction of meat intake, malnutrition,
and muscle wasting, and in addition, increased extrarenalchronic renal disease. Although serum creatinine is the
most commonly used measure of renal function in both elimination of creatinine resulting from degradation of
creatinine by intestinal microorganisms. Altogether, thesehealth and disease, it has several pitfalls, especially among
patients with chronic renal disease [11, 12]. In principle, factors blunt the expected rise in SCr as GFR declines.
Hence, the use of the SCr alone to estimate the levelserum creatinine reflects the ratio of urine creatinine
excretion and creatinine clearance. In normal individu- of renal function in chronic renal disease may lead to
substantial overestimation of the level of GFR, especiallyals, creatinine is excreted principally by glomerular fil-
tration, with tubular secretion of creatinine accounting in patients with reduced muscle mass.
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Table 2. Mean serum creatinine and predicted GFR at start of dialysis by diabetes status in the U.S. ESRD population incident between
1995 and 1997
Serum creatinine mg/dl Predicted GFR ml/min/1.73 m2
ESRD ESRD ESRD ESRD
due to due to due to due to
Alla diabetes other causes Alla diabetes other causes
Overall, mean (sd) 8.5 (3.8) 7.5 (2.9) 9.3 (4.2) 7.1 (3.1) 7.7 (3.0) 6.7 (3.0)
Age group years
18–24 12.7 (5.7) 9.0 (3.9) 13.0 (5.7) 6.0 (2.9) 7.6 (2.8) 5.9 (2.8)
25–34 11.3 (5.0) 8.7 (3.2) 12.5 (5.2) 6.3 (2.8) 7.5 (3.0) 5.8 (2.6)
35–44 10.6 (4.6) 8.5 (3.2) 11.7 (4.9) 6.4 (2.8) 7.4 (3.0) 5.8 (2.6)
45–54 9.5 (4.0) 8.3 (3.2) 10.8 (4.4) 6.6 (2.8) 7.2 (2.8) 6.0 (2.7)
55–64 8.4 (3.4) 7.7 (2.8) 9.4 (3.8) 7.1 (2.9) 7.5 (2.9) 6.5 (2.8)
65–74 7.7 (3.0) 7.0 (2.5) 8.2 (3.2) 7.5 (3.1) 7.9 (3.1) 7.1 (3.0)
75–84 7.2 (2.8) 6.5 (2.4) 7.5 (2.9) 7.8 (3.3) 8.3 (3.3) 7.5 (3.2)
851 6.9 (2.8) 6.5 (2.5) 7.0 (2.8) 7.8 (3.3) 8.1 (3.4) 7.8 (3.3)
Gender
Male 9.2 (4.0) 8.1 (3.0) 9.9 (4.4) 7.4 (3.2) 8.1 (3.1) 7.0 (3.1)
Female 7.8 (3.4) 7.0 (2.6) 8.6 (3.9) 6.8 (2.9) 7.3 (2.9) 6.3 (2.8)
Race
Caucasian 7.9 (3.3) 7.1 (2.6) 8.5 (3.6) 7.3 (3.1) 7.8 (3.1) 6.9 (3.0)
African American 9.9 (4.4) 8.4 (3.2) 10.9 (4.9) 7.0 (3.1) 7.6 (3.0) 6.5 (3.0)
Other 8.9 (3.8) 7.9 (2.9) 10.1 (4.3) 6.5 (2.8) 7.0 (2.9) 5.9 (2.6)
Weight kg
10–59 7.8 (3.5) 6.9 (2.7) 8.3 (3.8) 7.3 (3.3) 7.8 (3.3) 6.9 (3.2)
59.1–70 8.5 (3.8) 7.4 (2.8) 9.3 (4.2) 7.2 (3.1) 7.7 (3.1) 6.8 (3.1)
70.1–83 8.8 (3.9) 7.7 (2.9) 9.8 (4.3) 7.1 (3.0) 7.6 (3.0) 6.6 (2.9)
.83 9.1 (3.9) 8.0 (3.0) 10.5 (4.4) 7.0 (2.8) 7.5 (2.8) 6.4 (2.8)
Body mass index kg/m2
,20 8.0 (3.7) 7.0 (2.8) 8.4 (3.9) 7.5 (3.4) 8.3 (3.5) 7.2 (3.3)
20–25 8.6 (3.9) 7.4 (2.8) 9.3 (4.3) 7.2 (3.1) 7.8 (3.1) 6.8 (3.0)
25–27 8.7 (3.8) 7.7 (2.9) 9.6 (4.3) 7.1 (3.0) 7.6 (3.0) 6.6 (3.0)
.27 8.7 (3.8) 7.7 (2.9) 9.9 (4.3) 6.9 (2.9) 7.4 (2.8) 6.4 (2.8)
Serum albumin g/dl
,2.5 8.3 (3.8) 7.4 (2.9) 9.1 (4.3) 6.6 (3.0) 7.0 (2.9) 6.2 (3.0)
2.5–2.99 8.3 (3.7) 7.5 (2.9) 9.2 (4.3) 6.9 (3.0) 7.4 (2.9) 6.5 (3.0)
3.0–3.49 8.4 (3.8) 7.6 (2.9) 9.3 (4.3) 7.2 (3.1) 7.7 (3.1) 6.7 (3.1)
3.5–3.99 8.7 (3.9) 7.5 (2.8) 9.4 (4.3) 7.3 (3.1) 8.1 (3.0) 6.9 (3.0)
4.0 9.1 (3.9) 7.6 (2.9) 9.6 (4.0) 7.3 (3.0) 8.3 (3.1) 7.0 (2.9)
BUN (mg/dl)
20–72 6.8 (2.4) 6.4 (2.1) 7.2 (2.7) 9.0 (3.4) 9.3 (3.4) 8.7 (3.5)
72.1–92 8.0 (2.7) 7.4 (2.4) 8.5 (2.9) 7.3 (2.6) 7.6 (2.6) 7.0 (2.5)
92.1–114 8.8 (3.4) 7.9 (2.8) 9.5 (3.7) 6.6 (2.5) 7.0 (2.6) 6.2 (2.4)
114.1–300 10.6 (5.1) 8.8 (3.7) 11.7 (5.4) 5.6 (2.6) 6.3 (2.6) 5.2 (2.5)
a P , 0.001 for all comparisons
The MDRD Study equation takes into account the independently associated with the level of predicted
GFR at the initiation of dialysis (Table 3). Patients withmost important factors that affect the relationship be-
tween serum creatinine and GFR, namely, age, gender, ESRD caused by diabetic nephropathy had a 1.0 ml/min/
1.73 m2 higher mean predicted GFR than patients withrace, and variables related to protein intake (BUN) and
nutritional status (SAlb). As expected, differences in mean ESRD because of other diseases. This is consistent with
the widely held belief that diabetic patients require initia-predicted GFR between subgroups defined by these vari-
ables are lower than differences in mean SCr (Fig. 2 and tion of dialysis earlier because of appearance of uremic
symptoms at higher levels of GFR. However, it mayTable 2). These results suggest that the differences in
mean SCr at the initiation of dialysis associated with the also reflect lower muscle mass in diabetic patients with
chronic renal disease related to more severe malnutritionpreviously mentioned factors partly reflect variations in
muscle mass, protein intake, and nutritional status. Rou- or more comorbid conditions. This latter explanation
is consistent with a 3% lower mean predicted GFR intine use of the MDRD Study equation to compute pre-
dicted GFR would allow physicians to focus more clearly diabetic patients in the MDRD Study baseline cohort.
However, the MDRD Study baseline cohort excludedon the level of renal function in patients with chronic
renal disease and might reduce some of the variability patients with insulin-dependent diabetes mellitus. There
were relatively few patients with non–insulin-dependentin the timing of the initiation of dialysis.
We observed several other important factors that were diabetes, and the relationship of diabetic status to pre-
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Table 3. Mean serum creatinine and predicted GFR at start of dialysis by diabetes status in the U.S. ESRD population incident between
1995 and 1997
Serum creatinine mg/dl Predicted GFR ml/min/1.73 m2
ESRD ESRD ESRD ESRD
due to due to due to due to
Alla diabetes other causes Alla diabetes other causes
Overall, mean (sd) 8.5 (3.8) 7.5 (2.9) 9.3 (4.2) 7.1 (3.1) 7.7 (3.0) 6.7 (3.0)
Insurance
Private 8.9 (3.8) 7.8 (2.9) 9.8 (4.2) 7.0 (3.0) 7.6 (3.0) 6.5 (2.9)
Medicare only 8.0 (3.3) 7.5 (2.8) 8.4 (3.6) 7.4 (3.1) 7.8 (3.0) 7.1 (3.2)
Medicaid only 9.3 (4.2) 7.9 (3.1) 10.7 (4.7) 6.8 (3.1) 7.4 (3.1) 6.2 (3.0)
Medicare and Medicaid 7.7 (3.2) 7.1 (2.7) 8.4 (3.6) 7.5 (3.1) 7.8 (3.1) 7.1 (3.0)
VAb or other insurance(s) 7.9 (3.3) 7.2 (2.7) 8.4 (3.6) 7.4 (3.1) 7.9 (3.1) 7.1 (3.1)
None 11.2 (5.0) 8.7 (3.5) 12.5 (5.2) 6.0 (2.7) 7.0 (2.8) 5.5 (2.5)
Employment
Employed/student/homemaker 9.6 (4.4) 7.9 (3.1) 10.6 (4.7) 6.5 (2.8) 7.2 (2.8) 6.1 (2.6)
Unemployed 9.2 (4.3) 7.8 (3.1) 10.4 (4.7) 6.8 (3.0) 7.4 (3.0) 6.3 (2.9)
Retired due to age/preference or disability
and medical leave of absence 7.8 (3.1) 7.3 (2.7) 8.2 (3.4) 7.6 (3.2) 7.9 (3.1) 7.3 (3.1)
Inability to transfer
Yes 7.0 (3.0) 6.6 (2.7) 7.3 (3.2) 8.1 (3.7) 8.4 (3.7) 7.8 (3.6)
No 8.6 (3.8) 7.6 (2.9) 9.4 (4.3) 7.1 (3.0) 7.6 (3.0) 6.7 (3.0)
Inability to ambulate
Yes 7.1 (3.0) 6.7 (2.7) 7.5 (3.3) 8.0 (3.4) 8.3 (3.5) 7.7 (3.4)
No 8.6 (3.8) 7.6 (2.9) 9.4 (4.3) 7.1 (3.0) 7.6 (3.0) 6.7 (3.0)
Initial dialysis modality
Hemodialysis 8.6 (3.9) 7.6 (2.9) 9.4 (4.3) 7.1 (3.1) 7.6 (3.0) 6.7 (3.0)
Peritoneal dialysis 8.4 (3.5) 7.4 (2.6) 9.2 (3.9) 7.4 (3.1) 8.0 (3.1) 6.9 (3.0)
Dialysis start year
1995 8.6 (3.8) 7.6 (2.9) 9.4 (4.3) 7.1 (3.0) 7.6 (3.0) 6.7 (3.0)
1996 8.5 (3.8) 7.5 (2.9) 9.3 (4.2) 7.1 (3.1) 7.6 (3.1) 6.7 (3.0)
1997 8.4 (3.8) 7.4 (2.9) 9.2 (4.2) 7.3 (3.1) 7.8 (3.1) 6.8 (3.0)
a P , 0.001 for all comparisons
b Veterans Affairs
dicted GFR was not significant in the multivariable anal- patients who selected peritoneal dialysis were more
likely to have received pre-ESRD care by a nephrologistysis. Possibly, use of a different prediction equation for
GFR, which includes a term for diabetic status, would and may have started dialysis in a planned and timely
manner [13, 14].reduce the difference in predicted GFR between patients
with diabetes and other causes of ESRD. Nonetheless, We also observed small, but significant differences in
predicted GFR by variables, which were included in thethe MDRD Study equation appears more accurate than
other commonly used prediction equations. MDRD Study equation (age, gender, race, BUN, and
serum albumin). The mean predicted GFR in womenWe also found significant associations between GFR
and insurance, employment, and type of initial dialysis was 0.6 ml/min/1.73 m2 lower than in men at the initiation
of dialysis, and this difference persisted after adjustmentmodality. Patients with no medical insurance had a 1.0
ml/min/1.73 m2 lower mean predicted GFR compared for all other variables. This suggests either that the
MDRD Study prediction equation is not accurate or thatwith patients with private medical insurance. The lower
GFR at initiation of dialysis among uninsured patients gender and other factors included in the MDRD Study
equation are associated with the SCr at the initiation ofmost likely reflects limited access to medical care. Pa-
tients who were employed, students, or homemakers also dialysis through mechanisms in addition to their effect
on creatinine secretion and excretion. Given the complexhad a lower mean predicted GFR compared with those
who were unemployed (0.3 ml/min/1.73 m2) or compared relationships of medical decision making with age, gen-
der, race, dietary intake, and nutritional status, we thinkwith those who had retired because of age or preference
or who were on medical leave of absence (1.1 ml/min/ the latter hypothesis is plausible. For example, in a previ-
ous analysis, we found that women, as compared with1.73 m2). This may reflect a later appearance of uremic
symptoms in patients who are healthy enough to con- men, were more likely to have low SAlb at the start of
dialysis and more severe anemia at the start of dialysistinue working. Finally, patients who were started on he-
modialysis had a 0.3 ml/min/1.73 m2 lower mean pre- and were less likely to have received erythropoietin prior
to the initiation of dialysis [15]. Altogether, these analy-dicted GFR than those who were started on peritoneal
dialysis. A possible explanation of this finding is that ses suggest that women begin dialysis at lower levels of
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these data are the responsibility of the author(s) and in no way shouldrenal function, with more severe comorbid conditions
be seen as an official policy or interpretation of the U.S. government.and with less prior medical treatment than men. The
reasons for these gender differences are unclear and Reprint requests to Andrew S. Levey, M.D., Division of Nephrology,
require further investigation. More research is also re- New England Medical Center, Box #391, 750 Washington Street, Boston,
Massachusetts 02111, USA.quired to uncover reasons for initiation of dialysis at
E-mail: ALevey@lifespan.orglower predicted GFR in younger individuals (0.3 ml/min/
1.73 m2 per decade).
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